Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANHelp H. pylori Treatment Trials
NCT01967329Phase 4Completed
- Sponsor
- University of Alberta
- Start
- Nov 2008
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of rabeprazole, amoxicillin, clarithromycin, metronidazole, bismuth subsalicylate and 1 more in Helicobacter pylori infection (7 arms), sponsored by University of Alberta. Primary endpoint: Post-treatment H. pylori status by urea breath test. Started Nov 2008; status: completed.
02
Drugs
rabeprazoleamoxicillinclarithromycinmetronidazolebismuth subsalicylate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT01967329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01967329.